BlackRock Health Sciences Trust II (BMEZ)vsBlackstone Group Inc (BX)
BMEZ
BlackRock Health Sciences Trust II
$16.50
-0.30%
FINANCIAL SERVICES · Cap: $1.03B
BX
Blackstone Group Inc
$124.96
-0.36%
FINANCIAL SERVICES · Cap: $149.90B
Smart Verdict
WallStSmart Research — data-driven comparison
BX leads profitability with a 22.7% profit margin vs 0.0%. BMEZ trades at a lower P/E of 4.8x. BX earns a higher WallStSmart Score of 75/100 (B+).
BMEZ
Avoid32
out of 100
Grade: F
BX
Strong Buy75
out of 100
Grade: B+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Conservative balance sheet, low leverage
Every $100 of equity generates 39 in profit
Strong operational efficiency at 54.4%
Earnings expanding 57.3% YoY
Large-cap with strong market position
Keeps 23 of every $100 in revenue as profit
Revenue surging 28.6% year-over-year
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 5.7% — below average capital efficiency
Moderate valuation
Trading at 11.1x book value
Elevated debt levels
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BMEZ
The strongest argument for BMEZ centers on P/E Ratio, Debt/Equity.
Bull Case : BX
The strongest argument for BX centers on Return on Equity, Operating Margin, EPS Growth. Profitability is solid with margins at 22.7% and operating margin at 54.4%. Revenue growth of 28.6% demonstrates continued momentum.
Bear Case : BMEZ
The primary concerns for BMEZ are Revenue Growth, EPS Growth, Market Cap.
Bear Case : BX
The primary concerns for BX are P/E Ratio, Price/Book, Debt/Equity. Debt-to-equity of 1.56 is elevated, increasing financial risk.
Key Dynamics to Monitor
BMEZ profiles as a value stock while BX is a growth play — different risk/reward profiles.
BX is growing revenue faster at 28.6% — sustainability is the question.
BX generates stronger free cash flow (1.9B), providing more financial flexibility.
Monitor ASSET MANAGEMENT industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BX scores higher overall (75/100 vs 32/100), backed by strong 22.7% margins and 28.6% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BlackRock Health Sciences Trust II
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
BlackRock Health Sciences Trust II (BMEZ) is a closed-end fund that focuses on delivering high total returns through a diversified portfolio primarily concentrated in the health sciences sector, which encompasses pharmaceuticals, biotechnology, and medical devices. Capitalizing on BlackRock's extensive industry knowledge, BMEZ targets significant growth opportunities driven by demographic shifts and increasing healthcare spending. With its disciplined investment approach and commitment to funding innovative healthcare solutions, BMEZ provides institutional investors a compelling avenue for portfolio enhancement in a dynamic and rapidly evolving market landscape.
Blackstone Group Inc
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Blackstone Group Inc. is an alternative asset management company specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity strategies and multiple asset classes. The company is headquartered in New York, New York with additional offices across Asia, Europe and North America.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?